By Marisa Wong and Cristal Cody
Los Angeles, Dec. 7 – Roche Holdings, Inc. priced $6 billion of notes in three parts on Monday, according to a market source.
Roche priced $2 billion of 1.93% notes due Dec. 13, 2028 with a spread of 55 basis points over Treasuries, $2 billion of 2.076% notes due Dec. 13, 2031 with a spread of 65 bps over Treasuries and $2 billion of 2.607% notes due Dec. 13, 2051 with a spread of 85 bps over Treasuries.
The company marketed the seven-year notes with a spread in the Treasuries plus 75 bps area. The 10-year tranche was heard to have initial talk in the Treasuries plus 85 bps area. And, the 30-year series was expected to have priced in the Treasuries plus 105 bps area.
BNP Paribas, Citigroup, Deutsche Bank and JPMorgan are the bookrunners.
The drug maker is based in Basel, Switzerland.
Issuer: | Roche Holdings, Inc.
|
Amount: | $6 billion
|
Issue: | Notes
|
Bookrunners: | BNP Paribas, Citigroup, Deutsche Bank and JPMorgan
|
Pricing date: | Dec. 6
|
|
Seven-year notes
|
Amount: | $2 billion
|
Maturity: | Dec. 13, 2028
|
Coupon: | 1.93%
|
Spread: | Treasuries plus 55 bps
|
Price talk: | Treasuries plus 75 bps area
|
|
10-year notes
|
Amount: | $2 billion
|
Maturity: | Dec. 13, 2031
|
Coupon: | 2.076%
|
Spread: | Treasuries plus 65 bps
|
Price talk: | Treasuries plus 85 bps area
|
|
30-year notes
|
Amount: | $2 billion
|
Maturity: | Dec. 13, 2051
|
Coupon: | 2.607%
|
Spread: | Treasuries plus 85 bps
|
Price talk: | Treasuries plus 105 bps area
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.